Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 15Prostate Adenocarcinoma 1Pain 1Metastatic Castration-resistant Prostate Cancer 1Fatigue 1Castration-resistant Prostate Cancer 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1

Interventions

Surveys and Questionnaires 15Acupuncture Therapy 15Fentanyl 14Morphine 13Acetaminophen 13Analgesia 12Lidocaine 11Ketamine 11Bupivacaine 11Methadone 10Therapeutics 9Ropivacaine 9Psychiatric Rehabilitation 9Oxycodone 9Hydromorphone 7Saline Solution 6Radiotherapy 6Music Therapy 6Early Intervention, Educational 6Zoledronic Acid 5Yoga 5Water 5Methods 5Control Groups 5Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Physical Therapy Modalities 4Massage 4Ketorolac 4Exercise 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pain × Radium-223 × Clear all
NCT02278055 2023-04-07

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
29 enrolled 10 charts
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡